Shareholder Votes

Amplitude, Inc. shareholders approved Election of Class II Directors at the 2026-06-09 meeting.

“The Company’s stockholders elected each of the three persons named below as a Class II director to serve until the Company’s 2029 annual meeting of stockholders, and until each such director’s respective successor is elected and qualified.”

Industrial Logistics Properties Trust shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent auditors for the 2026 fiscal year at the 2026-06-09 meeting.

“The Company’s shareholders also ratified the appointment of Deloitte & Touche LLP as the Company’s independent auditors to serve for the 2026 fiscal year.”

Industrial Logistics Properties Trust shareholders voted on Non-binding advisory vote on the frequency of future shareholder advisory votes to approve executive compensation at the 2026-06-09 meeting.

“The Company’s shareholders also voted on a non-binding advisory vote on the frequency of future shareholder advisory votes to approve executive compensation.”

Industrial Logistics Properties Trust shareholders approved Non-binding advisory resolution on the compensation paid to the Company’s named executive officers at the 2026-06-09 meeting.

“The Company’s shareholders also voted on a non-binding advisory resolution on the compensation paid to the Company’s named executive officers as disclosed pursuant to Item 402 of Regulation S-K in the Company’s proxy statement relating to the Annual Meeting.”

Industrial Logistics Properties Trust shareholders approved Election of seven Trustees to the Board each for a one year term at the 2026-06-09 meeting.

“At the Company’s annual meeting of shareholders held on June 9, 2026 (the “Annual Meeting”), the Company’s shareholders voted on the election of seven Trustees to the Board each for a one year term of office continuing until the Company’s 2027 annual meeting of shareholders and until her or his respective successor is duly elected and qualifies.”

Rapport Therapeutics, Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-10 meeting.

“Proposal 2 - Ratification of Appointment of the Company’s Independent Registered Public Accounting Firm The Company’s stockholders ratified the selection of PwC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of Proposal 2 were as follows: For Against Abstain 44,255,547 57,445 19,919”

Rapport Therapeutics, Inc. shareholders approved Election of Class II directors: James Healy, M.D., Ph.D., Robert J. Perez, and Raymond Sanchez, M.D. at the 2026-06-10 meeting.

“Proposal 1 - Election of Class I Director Nominees The Company’s stockholders approved the Class II director nominees recommended for election in Proposal 1 at the Annual Meeting. The results of Proposal 1 were as follows: Class II Director Nominee For Withheld Broker Non-Votes James Healy, M.D., Ph.D. 41,762,713 587,163 1,983,035 Robert J. Perez 37,592,089 4,757,787 1,983,035 Raymond Sanchez, M.D. 41,754,131 595,745 1,983,035”

INFINITY NATURAL RESOURCES, INC. shareholders approved Approval, pursuant to NYSE Rule 312.03, of the issuance of shares of Class A common stock upon conversion of shares of Series A Convertible Preferred Stock or otherwise issued pursuant to the Securities Purchase Agreement and the corresponding Certificate of Designation at the 2026-06-09 meeting.

“Proposal 5. To approve, pursuant to NYSE Rule 312.03, the issuance of shares of Class A common stock upon the conversion of shares of Series A Convertible Preferred Stock, or otherwise issued pursuant to the Securities Purchase Agreement and the corresponding Certificate of Designation: For Against Abstain Broker Non-Votes 70,707,702 332,588 4,940 1,343,514”

INFINITY NATURAL RESOURCES, INC. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-09 meeting.

“Proposal 4. To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026: For Against Abstain 71,608,697 779,811 236”

INFINITY NATURAL RESOURCES, INC. shareholders approved Recommendation, by a non-binding advisory vote, of the frequency of future advisory votes to approve the compensation of the Company's named executive officers at the 2026-06-09 meeting.

“Proposal 3. To recommend, by a non-binding advisory vote, the frequency of future advisory votes to approve the compensation of the Company's named executive officers: Every One Year Every Two Years Every Three Years Abstain Broker Non-Votes 71,032,634 1,390 6,229 4,977 1,343,514”

INFINITY NATURAL RESOURCES, INC. shareholders approved Approval, by a non-binding advisory vote, of the compensation of the Company's named executive officers at the 2026-06-09 meeting.

“Proposal 2. To approve, by a non-binding advisory vote, the Company's named executive officer compensation: For Against Abstain Broker Non-Votes 67,036,003 2,484,190 1,525,037 1,343,514”

INFINITY NATURAL RESOURCES, INC. shareholders approved Election of eight directors to the Board for terms expiring at the 2027 Annual Meeting of Stockholders at the 2026-06-09 meeting.

“Proposal 1. To elect eight directors to the Board for terms expiring at the 2027 Annual Meeting of Stockholders: For Withheld Broker Non-Votes Zack Arnold 70,996,650 48,580 1,343,514 Steven Cobb 70,994,712 50,518 1,343,514 Katherine M. Gallagher 62,070,854 8,974,376 1,343,514 Scott Gieselman 70,960,415 84,815 1,343,514 Steven D. Gray 70,991,255 53,975 1,343,514 Scott McNeill 71,001,813 43,417 1,343,514 David Poole 68,319,094 2,726,136 1,343,514 William J. Quinn 70,994,762 50,468 1,343,514”

BRT Apartments Corp. shareholders approved To approve the 2026 Incentive Plan at the 2026-06-10 meeting.

“Proposal 4– To approve the 2026 Incentive Plan For Against Abstain Broker Non-Vote 12,887,442 1,460,559 47,191 2,487,398”

BRT Apartments Corp. shareholders approved Ratification of the selection of Independent Registered Public Accounting Firm at the 2026-06-10 meeting.

“Proposal 3– Ratification of the selection of Independent Registered Public Accounting Firm To ratify of the selection of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026: For Against Abstain 16,693,688 162,882 26,020”

BRT Apartments Corp. shareholders approved Advisory Vote on Executive Compensation at the 2026-06-10 meeting.

“Proposal 2– Advisory Vote on Executive Compensation To approve, by non-binding vote, executive compensation for the year ended December 31, 2025: For Against Abstain Broker Non-Vote 13,967,597 201,767 225,828 2,487,398”

BRT Apartments Corp. shareholders approved Election of Directors at the 2026-06-10 meeting.

“Proposal 1 - Election of Directors To elect the directors named below for a term expiring at the 2029 annual meeting of the stockholders: For Against Abstain Broker Non-Vote Carol Cicero 12,550,266 1,808,509 36,417 2,487,398 Frederic H. Gould 13,475,355 899,564 20,273 2,487,398 Gary Hurand 12,014,545 2,360,366 20,281 2,487,398 Elie Weiss 13,883,328 412,133 99,731 2,487,398”

Ralliant Corp shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company's independent auditor for fiscal 2026 at the 2026-06-05 meeting.

“Proposal 4: Ratification of the appointment of Ernst & Young LLP as the Company’s independent auditor for fiscal 2026 VOTES FOR VOTES AGAINST ABSTENTIONS BROKER NON-VOTES 100,912,738 70,243 147,493 N/A”

Ralliant Corp shareholders approved Advisory vote on the frequency of future advisory votes to approve the Company's named executive officer compensation at the 2026-06-05 meeting.

“Proposal 3: Advisory vote on the frequency of future advisory votes to approve the Company’s named executive officer compensation 1 YEAR 2 YEARS 3 YEARS ABSTENTIONS BROKER NON-VOTES 93,908,342 41,312 1,339,154 166,679 5,674,987”

Ralliant Corp shareholders approved Advisory vote to approve the Company's named executive officer compensation in fiscal 2025 at the 2026-06-05 meeting.

“Proposal 2: Advisory vote to approve the Company’s named executive officer compensation in fiscal 2025 VOTES FOR VOTES AGAINST ABSTENTIONS BROKER NON-VOTES 93,154,434 2,134,542 166,511 5,674,987”

Ralliant Corp shareholders approved Election of Class I directors for a three-year term at the 2026-06-05 meeting.

“Proposal 1: Election of Class I directors for a three-year term VOTES FOR VOTES AGAINST ABSTENTIONS BROKER NON-VOTES Luis Müller 93,284,737 2,011,462 159,288 5,674,987 Anelise Sacks 94,813,394 483,609 158,484 5,674,987 Neil Schrimsher 94,660,646 635,627 159,214 5,674,987”

Prelude Therapeutics Inc shareholders approved Advisory vote on the frequency of advisory votes on the compensation for the Company's named executive officers at the 2026-06-09 meeting.

“4. Advisory vote on the frequency of advisory votes on the compensation for the Company's named executive officers, based on the following votes: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 26,877,941 65,638 103,237 5,941 4,799,016”

Prelude Therapeutics Inc shareholders approved Advisory vote to approve the 2025 compensation for the Company's named executive officers at the 2026-06-09 meeting.

“3. Advisory vote to approve the 2025 compensation for the Company's named executive officers, based on the following votes: Shares For Shares Against Shares Abstaining Broker Non-Votes 26,869,142 107,500 76,115 4,799,016”

Prelude Therapeutics Inc shareholders approved Ratification of appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026 at the 2026-06-09 meeting.

“2. Ratification of appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026, based on the following votes: Shares For Shares Against Shares Abstaining Broker Non-Votes 31,841,080 4,951 5,742 0”

Prelude Therapeutics Inc shareholders approved Election of three Class III Directors, Krishna Vaddi, Paul Scherer, and Katina Dorton, each to serve a three-year term, which will expire at the 2029 Annual Meeting of Stockholders and until such time as their respective successors have been duly elected and qualified or until such director’s earlie at the 2026-06-09 meeting.

“On June 9, 2026, Prelude Therapeutics Incorporated (the "Company") held its 2026 Annual Meeting of Stockholders (the "Annual Meeting") and the following proposals were approved by the Company's stockholders: 1. Election of three Class III Directors, Krishna Vaddi, Paul Scherer, and Katina Dorton, each to serve a three-year term, which will expire at the 2029 Annual Meeting of Stockholders and until such time as their respective successors have been duly elected and qualified or until such director’s earlier resignation or removal, based on the following votes: Nominees Shares For Shares Withheld Broker Non-Votes Krishna Vaddi, Ph.D. 26,996,820 55,937 4,799,016 Paul Scherer, MD, Ph.D. 25,532,267 1,520,490 4,799,016 Katina Dorton, J.D., MBA 26,998,601 54,156 4,799,016”

Reddit, Inc. shareholders approved Non-binding advisory vote on compensation of named executive officers at the 2026-06-08 meeting.

“Proposal 3: Advisory Vote on the Compensation of the Company’s Named Executive Officers. Votes For Votes Against Abstentions Broker Non-Votes 548,116,258 10,731,180 87,007 27,814,136”

Reddit, Inc. shareholders approved Ratification of appointment of KPMG LLP as independent registered public accounting firm for 2026 at the 2026-06-08 meeting.

“Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm. Votes For Votes Against Abstentions Broker Non-Votes 586,179,407 367,200 201,974 0”

Reddit, Inc. shareholders approved Election of eight directors to serve until 2027 annual meeting at the 2026-06-08 meeting.

“Proposal 1: Election of Directors. Nominee Votes For Votes Withheld Broker Non-Votes Steven Huffman 544,587,512 14,346,933 27,814,136 Sarah Farrell 558,122,698 811,747 27,814,136 Patricia Fili-Krushel 557,521,576 1,412,869 27,814,136 Porter Gale 558,211,637 722,808 27,814,136 David Habiger 549,471,923 9,462,522 27,814,136 Steven O. Newhouse 503,672,730 55,261,715 27,814,136 Robert A. Sauerberg Jr. 523,063,967 35,870,478 27,814,136 Michael Seibel 541,452,381 17,482,064 27,814,136”

Virtu Financial, Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-10 meeting.

“The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified. The votes for the ratification of the appointment of PricewaterhouseCoopers LLP are set forth below: For Against Abstain 679,397,651 659,952 40,619”

Virtu Financial, Inc. shareholders approved Advisory approval of the compensation of named executive officers at the 2026-06-10 meeting.

“The compensation of the Company’s named executive officers was approved, on an advisory basis. The advisory votes are set forth below: For Against Abstain Broker Non-Votes 663,861,829 8,042,616 53,464 8,140,313”

Virtu Financial, Inc. shareholders approved Election of Class II Directors at the 2026-06-10 meeting.

“Each of the director nominees listed below was elected a Class II director of the Company to act in accordance with the amended and restated bylaws of the Company for a term of three years expiring at the annual meeting of stockholders to be held in 2029 and until such director's successor has been duly elected and qualified. The votes for the election of directors are set forth below: Nominee For Withheld Broker Non-Votes Aaron Simons 671,181,435 776,474 8,140,313 Joseph J. Grano, Jr. 655,260,181 16,697,728 8,140,313 Joanne M. Minieri 645,673,037 26,284,872 8,140,313”

enGene Therapeutics Inc. shareholders approved Appointment and Remuneration of Auditor at the 2026-06-09 meeting.

“Proposal 2 – Appointment and Remuneration of Auditor For Withhold Broker Non-Votes 56,180,287 16,015 -”

enGene Therapeutics Inc. shareholders approved Election of Directors at the 2026-06-09 meeting.

“Proposal 1 – Election of Directors Director Nominee For Withhold Broker Non-Votes Philip Astley-Sparke 47,112,414 306,821 8,777,067 Ronald H.W. Cooper 47,329,848 89,387 8,777,067 Dr. William Grossman 47,408,163 11,072 8,777,067 Michael Heffernan 47,408,163 11,072 8,777,067”

YELP INC shareholders approved Approval of amendment and restatement of the 2012 Employee Stock Purchase Plan at the 2026-06-05 meeting.

“The Company’s stockholders approved the Restated ESPP. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes Percentage of Votes In Favor 44,278,578 276,172 18,504 6,466,581 99.3%”

YELP INC shareholders approved Advisory vote to approve named executive officer compensation at the 2026-06-05 meeting.

“The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes Percentage of Votes In Favor 41,743,122 2,796,717 33,415 6,466,581 93.7%”

YELP INC shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm at the 2026-06-05 meeting.

“The Company’s stockholders ratified the selection made by the Audit Committee of the Company’s Board of Directors of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes Percentage of Votes In Favor 50,756,544 234,427 48,864 — 99.4%”

YELP INC shareholders approved Election of nine directors at the 2026-06-05 meeting.

“Each of the nine nominees for director was elected to serve until the Company’s 2027 Annual Meeting of Stockholders, or until his or her successor has been duly elected and qualified. The voting results were as follows: Director Name Votes For Votes Against Abstentions Broker Non-Votes Percentage of Votes In Favor Fred D. Anderson, Jr. 43,614,940 920,005 38,309 6,466,581 97.9% Christine Barone 44,318,372 240,917 13,965 6,466,581 99.5% Robert Gibbs 43,574,293 984,143 14,818 6,466,581 97.8% Logan Green 44,403,303 155,148 14,803 6,466,581 99.7% Diane Irvine 43,163,259 1,395,240 14,755 6,466,581 96.9% Dan Jedda 44,378,245 180,195 14,814 6,466,581 99.6% Sharon Rothstein 43,903,963 648,507 20,784 6,466,581 98.5% Jeremy Stoppelman 44,138,944 420,404 13,906 6,466,581 99.1% Tony Wells 44,302,948 255,694 14,612 6,466,581 99.4%”

Rapid7, Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-09 meeting.

“Proposal 3 - Advisory Vote on Executive Compensation The Company’s stockholders approved, on a non-binding advisory basis, Proposal 3.”

Rapid7, Inc. shareholders approved Ratification of the selection of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-09 meeting.

“Proposal 2 - Ratification of the Selection by the Audit Committee of the Board of Directors of KPMG LLP as the Independent Registered Public Accounting Firm of the Company for its Fiscal Year Ending December 31, 2026 The Company’s stockholders approved Proposal 2.”

Rapid7, Inc. shareholders approved Election of eleven nominees for director at the 2026-06-09 meeting.

“Proposal 1 - Election of Directors The Company’s stockholders approved Proposal 1.”

Seven Hills Realty Trust shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent auditors to serve for the 2026 fiscal year. at the 2026-06-10 meeting.

“The Company’s shareholders also ratified the appointment of Deloitte & Touche LLP as the Company’s independent auditors to serve for the 2026 fiscal year. This proposal received the following votes: For Against Abstain Broker Non-Votes 18,380,982 542,376 143,142 N/A”

Seven Hills Realty Trust shareholders approved Election of two Independent Trustees and one Managing Trustee in Class I of the Board, each for a three year term of office continuing until the Company's 2029 annual meeting of shareholders and until their respective successor is duly elected and qualifies. at the 2026-06-10 meeting.

“At the Annual Meeting, the Company’s shareholders voted on the election of two Independent Trustees and one Managing Trustee in Class I of the Board, each for a three year term of office continuing until the Company’s 2029 annual meeting of shareholders and until her or his respective successor is duly elected and qualifies. The following persons were elected as Trustees and received the following votes: Nominee Votes For Withhold Broker Non-Votes Ann M. Danner 12,668,995 1,063,799 5,333,706 William A. Lamkin 11,708,471 2,024,323 5,333,706 Matthew P. Jordan 13,097,434 635,360 5,333,706”

Entrada Therapeutics, Inc. shareholders approved Approve Amendment No. 1 to the 2021 Employee Stock Purchase Plan (2021 ESPP Amendment) to modify the evergreen provision at the 2026-06-10 meeting.

“The 2021 ESPP Amendment was approved. The results of the stockholders’ vote with respect to such approval were as follows: FOR AGAINST ABSTAIN BROKER NON-VOTES 16,780,217 7,475,514 3,730 8,930,773”

Entrada Therapeutics, Inc. shareholders approved Approve Amendment No. 1 to the 2021 Stock Option and Incentive Plan (2021 Plan Amendment) to modify the evergreen provision at the 2026-06-10 meeting.

“The 2021 Plan Amendment was approved. The results of the stockholders’ vote with respect to such approval were as follows: FOR AGAINST ABSTAIN BROKER NON-VOTES 14,686,713 9,566,186 6,562 8,930,773”

Entrada Therapeutics, Inc. shareholders approved Ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2026 at the 2026-06-10 meeting.

“The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified. The results of the stockholders’ vote with respect to such ratification were as follows: FOR AGAINST ABSTAIN 33,132,550 49,650 8,034”

Entrada Therapeutics, Inc. shareholders approved Election of two Class II directors: Peter S. Kim, Ph.D. and Bernhardt Zeiher, M.D. at the 2026-06-10 meeting.

“Peter S. Kim, Ph.D. and Bernhardt Zeiher, M.D. were duly elected to the Board as Class II directors. The results of the stockholders’ vote with respect to the election were as follows: CLASS II DIRECTOR NOMINEES FOR WITHHELD BROKER NON-VOTES Peter S. Kim, Ph.D. 22,181,490 2,077,971 8,930,773 Bernhardt Zeiher, M.D. 22,315,323 1,944,138 8,930,773”

CREDIT ACCEPTANCE CORP shareholders approved Ratification of the selection of Grant Thornton LLP as our independent registered public accounting firm for 2026 at the 2026-06-10 meeting.

“Ratification of the selection of Grant Thornton LLP as our independent registered public accounting firm for 2026: For Against Abstain Broker Non Votes 7,927,281 330,863 191 —”

CREDIT ACCEPTANCE CORP shareholders approved Approval of the advisory vote on named executive officer compensation at the 2026-06-10 meeting.

“Approval of the advisory vote on named executive officer compensation: For Against Abstain Broker Non Votes 5,229,825 1,056,747 1,908 1,969,855”

CREDIT ACCEPTANCE CORP shareholders approved Election of six directors to serve until the 2027 annual meeting at the 2026-06-10 meeting.

“Election of six directors to serve until the 2027 Annual Meeting of Shareholders: Director Nominees For Withheld Broker Non Votes Kenneth S. Booth 5,861,709 426,771 1,969,855 Glenda J. Flanagan 5,383,677 904,803 1,969,855 Vinayak R. Hegde 6,269,849 18,631 1,969,855 Sean E. Quinn 5,961,715 326,765 1,969,855 Thomas N. Tryforos 5,581,004 707,476 1,969,855 Scott J. Vassalluzzo 5,343,627 944,853 1,969,855”

Grand Canyon Education, Inc. shareholders approved Ratification of appointment of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-10 meeting.

“The stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Grand Canyon Education, Inc. shareholders approved Advisory approval of the compensation of the Company's named executive officers at the 2026-06-10 meeting.

“The stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers.”